ABMD ABIOMED, Inc.
ABIOMED, Inc. (ABIOMED) provides medical products and services in the area of circulatory care. The two products of the Company designed for heart recovery following acute events are the BVS 5000 Biventricular Support System (BVS) and the AB5000 Circulatory Support System (AB5000). The Company's Impella products are Conformite Europeenne (CE) marked in Europe. The AB5000 Circulatory Support System is a heart-assist product designed to provide enhanced patient mobility within and between medical centers to facilitate patient ambulation. In May 2005, ABIOMED completed the acquisition of Impella CardioSystems AG (Impella). Impella manufactures, sells and supports micro blood pumps with integrated motors and sensors for use in interventional cardiology and heart surgery.
Stock history for ABMD ABIOMED, Inc.
WallStreet Direct, Inc. Strengthens Online Community With Cutting-Edge Social Media Tools for Public Company Executives (PR Newswire)WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. , and the owner and operator of Wall St. Network the leading web 2.0 financial social networking community for investors and traders worldwide, today announced the launch of several social media platforms that enable public company executives to enhance web exposure, and directly communicate with current and potential shareholders.
Read 
[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: ABMD, DIT, ESPH, GCEH, UBRG (PR Newswire)Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company executives on their company and most recent press releases.
Read
Flu Season is Here: How to Detect Symptoms of Viral Myocarditis in Children and Young Adults (Business Wire)DANVERS, Mass.----Influenza, strep throat and the common cold afflict many people during the winter months, particularly in children and young adults, yet there is one often undiagnosed viral condition that can be far deadlier then these common viruses.
Read
Abiomed to Present at JP Morgan 27th Annual Healthcare Conference in San Francisco (Business Wire)DANVERS, Mass.----Abiomed, Inc. today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the 27th Annual JP Morgan Healthcare Conference on Wednesday, January 14, 2009 at 11:30 a.m.
Read
Abiomed names Robert Bowen chief financial officer (AP)Heart treatment products maker Abiomed Inc. said Monday it named Robert L. Bowen chief financial officer. Ian McLeod, who has served as Abiomed's interim principal financial and accounting officer, will remain the company's corporate controller.
Read
Abiomed Announces Record Revenue of $20 Million, Representing 75% Growth for Second Quarter of Fiscal 2009 (Business Wire)DANVERS, Mass.----Abiomed, Inc. today announced second quarter of fiscal 2009 revenue of $20.0 million, up 75% compared to revenue of $11.4 million for the same period of fiscal 2008.
Read
Abiomed Appoints Robert L. Bowen as Chief Financial Officer (Business Wire)DANVERS, Mass.----Abiomed, Inc. , a leading provider of heart recovery products providing circulatory support to acute heart failure patients, announced today the appointment of Robert L.
Read
ABIOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online) Read
Finance news provided by Yahoo! Finance.
